383 related articles for article (PubMed ID: 28539272)
1. Selenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanism.
Deng W; Xie Q; Wang H; Ma Z; Wu B; Zhang X
Nanomedicine; 2017 Aug; 13(6):1965-1974. PubMed ID: 28539272
[TBL] [Abstract][Full Text] [Related]
2. Selenium-layered nanoparticles serving for oral delivery of phytomedicines with hypoglycemic activity to synergistically potentiate the antidiabetic effect.
Deng W; Wang H; Wu B; Zhang X
Acta Pharm Sin B; 2019 Jan; 9(1):74-86. PubMed ID: 30766779
[TBL] [Abstract][Full Text] [Related]
3. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect.
Yin J; Hou Y; Yin Y; Song X
Int J Nanomedicine; 2017; 12():8671-8680. PubMed ID: 29263662
[TBL] [Abstract][Full Text] [Related]
4. Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery.
Li Y; Ji W; Peng H; Zhao R; Zhang T; Lu Z; Yang J; Liu R; Zhang X
Theranostics; 2021; 11(9):4452-4466. PubMed ID: 33754071
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antidiabetic properties of chitosan-stabilized selenium nanoparticles.
Zeng S; Ke Y; Liu Y; Shen Y; Zhang L; Li C; Liu A; Shen L; Hu X; Wu H; Wu W; Liu Y
Colloids Surf B Biointerfaces; 2018 Oct; 170():115-121. PubMed ID: 29894831
[TBL] [Abstract][Full Text] [Related]
6. Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy.
Singh S; Kushwah V; Agrawal AK; Jain S
Nanomedicine (Lond); 2018 Mar; 13(5):521-537. PubMed ID: 29383973
[TBL] [Abstract][Full Text] [Related]
7. [Poly(arginine)8 enhanced intestinal absorption of insulin-loaded nanoparticles].
Liu XL; Zhang WJ; Wei G; Lu WY
Yao Xue Xue Bao; 2012 Apr; 47(4):512-6. PubMed ID: 22799036
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-decorated selenium nanoparticles as protein carriers to improve the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2 diabetes mellitus.
Rao L; Ma Y; Zhuang M; Luo T; Wang Y; Hong A
Int J Nanomedicine; 2014; 9():4819-28. PubMed ID: 25378923
[TBL] [Abstract][Full Text] [Related]
10. Selenium nanoparticles and metformin ameliorate streptozotocin-instigated brain oxidative-inflammatory stress and neurobehavioral alterations in rats.
Ebokaiwe AP; Okori S; Nwankwo JO; Ejike CECC; Osawe SO
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):591-602. PubMed ID: 33064168
[TBL] [Abstract][Full Text] [Related]
11. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
12. Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation.
Liu L; Zhou C; Xia X; Liu Y
Int J Nanomedicine; 2016; 11():761-9. PubMed ID: 26966360
[TBL] [Abstract][Full Text] [Related]
13. Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats.
Al-Quraishy S; Dkhil MA; Abdel Moneim AE
Int J Nanomedicine; 2015; 10():6741-56. PubMed ID: 26604749
[TBL] [Abstract][Full Text] [Related]
14. A Nanocomposite Vehicle Based on Metal-Organic Framework Nanoparticle Incorporated Biodegradable Microspheres for Enhanced Oral Insulin Delivery.
Zhou Y; Liu L; Cao Y; Yu S; He C; Chen X
ACS Appl Mater Interfaces; 2020 May; 12(20):22581-22592. PubMed ID: 32340452
[TBL] [Abstract][Full Text] [Related]
15. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
16. A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects.
Zhao SJ; Wang DH; Li YW; Han L; Xiao X; Ma M; Wan DC; Hong A; Ma Y
Int J Nanomedicine; 2017; 12():2143-2160. PubMed ID: 28356733
[TBL] [Abstract][Full Text] [Related]
17. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats.
Salvioni L; Fiandra L; Del Curto MD; Mazzucchelli S; Allevi R; Truffi M; Sorrentino L; Santini B; Cerea M; Palugan L; Corsi F; Colombo M
Pharmacol Res; 2016 Aug; 110():122-130. PubMed ID: 27181095
[TBL] [Abstract][Full Text] [Related]
18. [Study on preparation and oral efficacy of insulin-loaded poly(lactic-co-glycolic acid) nanoparticles].
Pan Y; Xu H; Zhao HY; Wei G; Zheng JM
Yao Xue Xue Bao; 2002 May; 37(5):374-7. PubMed ID: 12579845
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Characterization of Hypoglycemic Nanoparticles for Oral Insulin Delivery.
Zhang L; Zhang YX; Qiu JN; Li J; Chen W; Guan YQ
Biomacromolecules; 2017 Dec; 18(12):4281-4291. PubMed ID: 29059517
[TBL] [Abstract][Full Text] [Related]
20. Phycocyanin-Functionalized Selenium Nanoparticles Reverse Palmitic Acid-Induced Pancreatic β Cell Apoptosis by Enhancing Cellular Uptake and Blocking Reactive Oxygen Species (ROS)-Mediated Mitochondria Dysfunction.
Liu C; Fu Y; Li CE; Chen T; Li X
J Agric Food Chem; 2017 Jun; 65(22):4405-4413. PubMed ID: 28510423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
